1-4 of 4
binding sites
Close
Sort by
Journal Articles

Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas

Xia Liu, Jiaji G. Chen, Manit Munshi, Zachary R. Hunter, Lian Xu, Amanda Kofides, Nickolas Tsakmaklis, Maria G. Demos, Maria Luisa Guerrera, Gloria G. Chan, Cristina Jimenez, Christopher J. Patterson, Kirsten Meid, Andrew Keezer, Jorge J. Castillo, Steven P. Treon, Guang Yang
Journal: Blood Advances
Blood Adv (2020) 4 (1): 141–153.
https://doi.org/10.1182/bloodadvances.2019000947
Published: 2020
Journal Articles

HoxA9 transforms murine myeloid cells by a feedback loop driving expression of key oncogenes and cell cycle control genes

Xiaoxia Zhong, Andreas Prinz, Julia Steger, Maria-Paz Garcia-Cuellar, Markus Radsak, Abderrazzak Bentaher, Robert K. Slany
Journal: Blood Advances
Blood Adv (2018) 2 (22): 3137–3148.
https://doi.org/10.1182/bloodadvances.2018025866
Published: 2018
Includes: Supplemental data
Journal Articles

VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites

Katrin J. Czogalla, Kerstin Liphardt, Klara Höning, Veit Hornung, Arijit Biswas, Matthias Watzka, Johannes Oldenburg
Journal: Blood Advances
Blood Adv (2018) 2 (6): 691–702.
https://doi.org/10.1182/bloodadvances.2017006775
Published: 2018
Includes: Supplemental data
Journal Articles

C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia

Justin Loke, Paulynn Suyin Chin, Peter Keane, Anna Pickin, Salam A. Assi, Anetta Ptasinska, Maria Rosaria Imperato, Peter N. Cockerill, Constanze Bonifer
Journal: Blood Advances
Blood Adv (2018) 2 (3): 271–284.
https://doi.org/10.1182/bloodadvances.2017012781
Published: 2018
Includes: Supplemental data